When patients present with identified bone metastases, a known primary diagnosis, and pain, the orthopaedic surgeon is nearly always contacted. The treatment plan is guided
Year: 2022
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
February 17, 2022 – For patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic drugs (bDMARDs) prior to orthopaedic surgery does
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
JBJS recently welcomed Antonia F. Chen, MD, MBA as Deputy Editor for Adult Reconstruction. Dr. Chen is an orthopaedic surgeon in Boston, Massachusetts. She also
JBJS has expanded the popular “What’s Important” article series to include a new section focused on creativity entitled “What’s Important: Arts & Humanities.” In the
Joshua J. Jacobs, MD has been named Chair of the Board of Trustees at The Journal of Bone and Joint Surgery (JBJS), Inc. An orthopaedic
Among the many challenges of the pandemic, the long-term health effects experienced by those who have had COVID-19 are an area of increasing focus. In
JBJS regularly publishes Current Concepts Review (CCR) articles, which provide concise and thorough reviews of the current literature on specific topics of interest to orthopaedic